PMID- 24026320
OWN - NLM
STAT- MEDLINE
DCOM- 20131113
LR  - 20131121
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 159
IP  - 5
DP  - 2013 Sep 3
TI  - Screening for peripheral artery disease and cardiovascular disease risk 
      assessment with the ankle-brachial index in adults: U.S. Preventive Services Task 
      Force recommendation statement.
PG  - 342-8
LID - 10.7326/0003-4819-159-5-201309030-00008 [doi]
AB  - DESCRIPTION: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) 
      recommendation on screening for peripheral artery disease (PAD). METHODS: The 
      USPSTF reviewed the evidence on the use of resting ankle-brachial index (ABI) as 
      a screening test for PAD or as a risk predictor for cardiovascular disease (CVD). 
      The review focused on resting ABI as the sole screening method; the diagnostic 
      performance of ABI testing in primary care populations, unselected populations, 
      and asymptomatic populations; the predictive value of ABI testing for major CVD 
      outcomes in primary care or unselected populations; and the effect of treatment 
      on general CVD and PAD-specific morbidity in patients with asymptomatic or 
      minimally symptomatic PAD. POPULATION: This recommendation applies to 
      asymptomatic adults who do not have a known diagnosis of PAD, CVD, severe chronic 
      kidney disease, or diabetes. RECOMMENDATION: The USPSTF concludes that the 
      current evidence is insufficient to assess the balance of benefits and harms of 
      screening for PAD and CVD risk assessment with the ABI in adults. (I statement).
FAU - Moyer, Virginia A
AU  - Moyer VA
CN  - U.S. Preventive Services Task Force
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
RN  - 0 (Fibrinolytic Agents)
RN  - R16CO5Y76E (Aspirin)
SB  - IM
SPIN- Ann Intern Med. 2013 Sep 3;159(5):I-28. PMID: 24026333
MH  - Adult
MH  - *Ankle Brachial Index
MH  - Aspirin/adverse effects/therapeutic use
MH  - Asymptomatic Diseases
MH  - Cardiovascular Diseases/*epidemiology
MH  - Cost of Illness
MH  - Early Diagnosis
MH  - Fibrinolytic Agents/adverse effects/therapeutic use
MH  - Hemorrhage/chemically induced
MH  - Humans
MH  - Mass Screening/adverse effects/*methods
MH  - Peripheral Arterial Disease/*diagnosis/drug therapy
MH  - Predictive Value of Tests
MH  - Risk Assessment
FIR - Moyer, Virginia A
IR  - Moyer VA
FIR - LeFevre, Michael L
IR  - LeFevre ML
FIR - Siu, Albert L
IR  - Siu AL
FIR - Baumann, Linda Ciofu
IR  - Baumann LC
FIR - Bibbins-Domingo, Kirsten
IR  - Bibbins-Domingo K
FIR - Curry, Susan J
IR  - Curry SJ
FIR - Ebell, Mark
IR  - Ebell M
FIR - Flores, Glenn
IR  - Flores G
FIR - Garcia, Francisco A R
IR  - Garcia FA
FIR - Cantu, Adelita Gonzales
IR  - Cantu AG
FIR - Grossman, David C
IR  - Grossman DC
FIR - Herzstein, Jessica
IR  - Herzstein J
FIR - Nicholson, Wanda K
IR  - Nicholson WK
FIR - Owens, Douglas K
IR  - Owens DK
FIR - Phillips, William R
IR  - Phillips WR
FIR - Pignone, Michael P
IR  - Pignone MP
FIR - Wilt, Timothy
IR  - Wilt T
EDAT- 2013/09/13 06:00
MHDA- 2013/11/14 06:00
CRDT- 2013/09/13 06:00
PHST- 2013/09/13 06:00 [entrez]
PHST- 2013/09/13 06:00 [pubmed]
PHST- 2013/11/14 06:00 [medline]
AID - 1733279 [pii]
AID - 10.7326/0003-4819-159-5-201309030-00008 [doi]
PST - ppublish
SO  - Ann Intern Med. 2013 Sep 3;159(5):342-8. doi: 
      10.7326/0003-4819-159-5-201309030-00008.